90 related articles for article (PubMed ID: 1253174)
1. The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice.
Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
Cancer Res; 1976 Mar; 36(3):1172-5. PubMed ID: 1253174
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy.
Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
Cancer Res; 1975 Nov; 35(11 Pt 1):3051-3. PubMed ID: 1182699
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
Drake WP; Cimino EF; Mardiney MR; Sutherland JC
J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
[No Abstract] [Full Text] [Related]
4. Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. I. Effect of single and double-stranded polynucleotides on Brucella abortus in vivo and in vitro.
Madraso ED; Cheers C
Immunology; 1978 Jul; 35(1):69-76. PubMed ID: 680803
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
6. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
Lacour J
J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
[No Abstract] [Full Text] [Related]
9. [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].
Lacour F; Lacour J; Spira A; Michelson M; Petit JY; Delage G; Contesso G; Merlin-Nahon E; Sarrazin D; Viguier J
Chirurgie; 1980 Nov; 106(9):737-43. PubMed ID: 7009093
[No Abstract] [Full Text] [Related]
10. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
[TBL] [Abstract][Full Text] [Related]
11. The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly U.
Pendergrast WJ; Drake WP; Mardiney MR
J Natl Cancer Inst; 1975 Nov; 55(5):1223-5. PubMed ID: 1206751
[TBL] [Abstract][Full Text] [Related]
12. A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
Ducret JP; Caillé P; Sancho Garnier H; Amiel JL; Michelson M; Hovanessian AG; Youn JK; Lacour F
J Biol Response Mod; 1985 Apr; 4(2):129-33. PubMed ID: 3998763
[TBL] [Abstract][Full Text] [Related]
13. Polyadenylic:polyuridylic acid-induced protection of BALB/c mice against acute murine cytomegalovirus infection.
Adams A; Mohrman M; Johnson AG; Morin A; Deschamps de Paillette E
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2409-13. PubMed ID: 1328496
[TBL] [Abstract][Full Text] [Related]
14. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant effect of polyadenylic.polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in mice.
Park SJ; Kim WH; Han KH; Chon CY; Hahm KB; Moon YM; Kang JK; Park IS; Youn JK
Int J Immunopharmacol; 1995 Jun; 17(6):513-6. PubMed ID: 7499028
[TBL] [Abstract][Full Text] [Related]
16. Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis.
Madraso ED; Cheers C
Immunology; 1978 Jul; 35(1):77-84. PubMed ID: 680804
[TBL] [Abstract][Full Text] [Related]
17. Polyadenylic-polyuridylic acid: biological response-modifying activities in mice. In vivo organ distribution and pharmacokinetics in rabbits.
Lacour F
J Biol Response Mod; 1985 Oct; 4(5):490-4. PubMed ID: 3878392
[TBL] [Abstract][Full Text] [Related]
18. Polyadenylic.polyuridylic acid in the cotreatment of cancer.
Michelson AM; Lacour F; Lacour J
Proc Soc Exp Biol Med; 1985 May; 179(1):1-8. PubMed ID: 2581264
[TBL] [Abstract][Full Text] [Related]
19. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial.
Lacour J; Laplanche A; Malafosse M; Gallot D; Julien M; Rotman N; Guivarc'h M; Roullet-Audy JC; Lasser P; Hautefeuille P
Eur J Surg Oncol; 1992 Dec; 18(6):599-604. PubMed ID: 1478293
[TBL] [Abstract][Full Text] [Related]
20. A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
Lacour F; Lacour J; Spira A; Michelson M; Delage G; Petit JY; Viguier J
Recent Results Cancer Res; 1982; 80():200-6. PubMed ID: 7036283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
